Management Team

Welcome to TRIZ Biopharma Innovation, the pioneering company behind Dynamic Self-Adapting Medical Drugs. We have developed a groundbreaking discovery that introduces a new paradigm in precision medicine—personalized and adaptive treatments that evolve in response to each patient’s unique biology. Unlike conventional drugs constrained by genetic variances, our dynamic drugs act like a ‘bunch of skeleton keys,’ ensuring nearly 100% efficacy by adapting to diverse biological targets. This revolutionary methodology integrates over 40 years of innovation, leveraging TRIZ (Theory of Inventive Problem Solving, based on patterns of evolution) in medicine and pharmaceuticals, along with cutting-edge AI technologies, to open the door to a transformative era in medicine. Join us as we redefine the future of healthcare with our visionary approach
Our Vision: Making drugs smart
Our Mission: Making the dream of personalized medicine come true: delivering smart drugs customized for everybody.


Boris Farber


Ph.D, Dr. Sci. Academician

Chief Executive Officer



ILya Kleyn



M.D., Medical Advisor



Daniel L. Beckles


M.D.,Ph.D.,FACS,FACC,FCCP

Chief Research Officer



Eduardo Javier Mascareno


Ph.D., Chief Research Officer



Irina E. Catrina


Ph.D., Assistant Professor of Chemistry

Advisor in Chemistry



Suzanna Katz


Ph.D., Senior Scientist



Stella Ilyayeva


MD, Advisor, Endocrinology



Alexander A. Katz


Prof., Ph.D., D.Sci. Advisor
Math Modeling and Drug Design


Avi Kamelhar


MPA, Business Advisor


Predrag-Peter Ilich


Dr., Regulatory Affairs and Compliance


James A. Warshaw


Ph.D, MD, ECNU, Advisor, Organic chemistry



Gabriel Ilyayev



Ph.D., Advisor, Pharmacology